Novo Nordisk CEO Lars Fruergaard Jorgensen discusses earnings as well as the competitive landscape in the pharmaceutical sector. He speaks with Bloomberg's Katie Greifeld and Alix Steel.

Sen. Rand Paul Talks US Debt, ICE, Future of DHS
12:21

Uber and Zoox CEOs Talk Robotaxi Partnership
08:35

Former St Louis Fed President Jim Bullard Talks Warsh's Nomination Process
05:53